|
TCEAL8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.938530E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.182600E-04 |
| Normal-vs-Stage2 |
3.000600E-01 |
| Normal-vs-Stage3 |
8.422600E-01 |
| Normal-vs-Stage4 |
1.297570E-03 |
| Stage1-vs-Stage2 |
7.080400E-01 |
| Stage1-vs-Stage3 |
7.614300E-02 |
| Stage1-vs-Stage4 |
4.409600E-01 |
| Stage2-vs-Stage3 |
3.369000E-01 |
| Stage2-vs-Stage4 |
3.283600E-01 |
| Stage3-vs-Stage4 |
2.660100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.156960E-03 |
| Normal-vs-AfricanAmerican |
1.915370E-01 |
| Normal-vs-Asian |
9.240600E-01 |
| Caucasian-vs-AfricanAmerican |
3.099600E-01 |
| Caucasian-vs-Asian |
2.485400E-01 |
| AfricanAmerican-vs-Asian |
5.670000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.01369999999201E-05 |
| Normal-vs-Female |
6.422800E-01 |
| Male-vs-Female |
1.046540E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.496210E-01 |
| Normal-vs-Extreme_Weight |
3.630500E-04 |
| Normal-vs-Obese |
2.219600E-01 |
| Normal-vs-Extreme_Obese |
1.186580E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.853400E-01 |
| Normal_Weight-vs-Obese |
7.394200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.826200E-01 |
| Extreme_Weight-vs-Obese |
6.041500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.871600E-01 |
| Obese-vs-Extreme_Obese |
4.439200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.943400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.216570E-01 |
| Normal-vs-Age(61-80Yrs) |
2.242000E-04 |
| Normal-vs-Age(81-100Yrs) |
6.189600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.247600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.831000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.750200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.235700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.054800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.701200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.204000E-04 |
| Normal-VS-Type2 PRCC |
1.618190E-01 |
| Normal-VS-KIRP CIMP |
4.31539999999897E-05 |
| Normal-VS-Unclassified PRCC |
1.030370E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.459010E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.235780E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.630200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.762800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.580600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.179700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.024500E-03 |
| Normal-vs-N1 |
9.251600E-01 |
| Normal-vs-N2 |
3.290200E-02 |
| N0-vs-N1 |
1.225040E-01 |
| N0-vs-N2 |
4.778200E-01 |
| N1-vs-N2 |
5.625900E-02 |
|
|
